BIOMAT Database Logo BIOMAT Database Logo

CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions. 1998

A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Laboratory of Cellular and Molecular Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1855, USA.

We tested infectious human immunodeficiency virus type 1 (HIV-1), noninfectious but conformationally authentic inactivated whole HIV-1 virions, and purified gp120 for the ability to induce depletion of CD4(+) T cells in human lymphoid tissues ex vivo. Infectious CXCR4-tropic HIV-1, but not matched inactivated virions or gp120, mediated CD4(+) T-cell depletion, consistent with mechanisms requiring productive infection.

UI MeSH Term Description Entries
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D015082 2,2'-Dipyridyl A reagent used for the determination of iron. 2,2-Bipyridine,Bipyridyl,alpha,alpha-Dipyridyl,2,2 Dipyridyl,2,2' Dipyridyl,2,2'-Bipyridine,2,2-Bipyridyl,2,2-Dipyridyl,2,2 Bipyridine,2,2 Bipyridyl,2,2' Bipyridine,Dipyridyl, 2,2,Dipyridyl, 2,2',alpha,alpha Dipyridyl
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III
D019718 Receptors, CXCR4 CXCR receptors with specificity for CXCL12 CHEMOKINE. The receptors may play a role in HEMATOPOIESIS regulation and can also function as coreceptors for the HUMAN IMMUNODEFICIENCY VIRUS. CXC Chemokine Receptor 4,CXCR4 Receptors,Fusin,CXCR4 Receptor,LESTR Receptor,Leukocyte-Derived Seven-Transmembrane Domain Receptor,Receptor, LESTR,Leukocyte Derived Seven Transmembrane Domain Receptor,Receptor, CXCR4
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.
September 2000, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.
November 2004, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo.
November 2001, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.
November 2007, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1.
October 2004, Virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
November 2004, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo.
January 2009, Retrovirology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
September 2005, Journal of virology,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo.
July 1996, The Journal of infectious diseases,
A W Sylwester, and J C Grivel, and W Fitzgerald, and J L Rossio, and J D Lifson, and L B Margolis
A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.
September 2012, The Journal of general virology,
Copied contents to your clipboard!